20+ year biotech investor, tech entrepreneur, and founder @ Biotech iQ. I focus on identifying derisked, high-alpha biotech/medtech investing ideas.biotechiq.netJoined April 2024
$SCPH BiQ was launched in Q1 2024. Here's our realized gains/losses since inception, including today's exit from SCPH. I decided not to wait for the CVRs, so SCPH was a 2.2x bagger instead of a 2.5x bagger, but I'd rather not wait around for the extra few cents.
$SCPH So, management sells for a low-ball valuation right on the cusp of full launch of FUROSCIX in CKD, and before launch of the auto-injector? 🤔
I love a buyout as much as the next bio-investor, but this is...disappointing.
Still a 2.5x win for BiQ, but this one was just…
$PGEN Papzimeos approved! Congratulations to all longs (and my fellow BiQ members) who held on through the volatility. The data was very approvable, so glad the FDA came through.
From the FDA press release:
“Randomized trials are not always needed to approve medical products…
$CTMX As most of us know, this is the paragraph in the PR that tanked the stock price:
"A single Grade 5 treatment-related acute kidney injury occured in a patient with a complex medical history including having a solitary kidney. The Grade 5 event was believed to be secondary…
$JOBY, which is one of the non-biotech holdings I follow at BiQ, posted what I consider to be very positive news today about a new defense collaboration with L3Harris. I remain long (c/b ~$4.00).
ir.jobyaviation.com/news-events/pr…
$ALLO Very sad news today of a patient death in the FC + ALLO-647 arm of the ALPHA3 trial. The death was attributed to hepatic failure caused by an adenovirus related infection in an immunosuppressed environment. The death was not attributed to Cema-Cel, and the trial will…
Great day for the biotech portfolio today. 2 BiQAP names up over 10% ( $IOVA up by 26% ), 6 other BiQAP names up by over 5%, and 6 names in the speculative portfolio up 10% or more. It's been a great couple of weeks, but I sure wouldn't mind a few more days like today...
$IOVA Congratulations to my fellow BiQ members who held on despite the overwhelming negative sentiment. Key challenges still remain, but I continue to believe in the potential for Amtagvi. Cash remains an issue, and management still needs to drive broader adoption. We're not out…
Biotech iQ Portfolio Update
There are currently 23 names in the BiQ Active Portfolio (BiQAP), of which 18 are green and 5 are red, but where I continue to have confidence. Overall, I'm very happy with the composition of the portfolio and am being very selective about adding new…
$TERN has been bouncing back nicely off lows at ~$2. I have a decent-sized position, but in retrospect, I probably should have added more exposure at those levels, but I was carefully conserving cash at the time. Q4 will be important for the company with the upcoming data for…
$EOSE isn't a biotech, but it's a company I like a lot. I still think Eos is being lumped in with clean energy plays, which is a mistake IMO. Eos helps clean energy, but its real value is in its ability to increase energy efficiency and stability at the grid and data center…
I'm very happy with the current composition of the Biotech iQ Active Portfolio. Currently tracking 23 companies in the BiQAP (and many more on the Watch List awaiting further derisking).
Out of the 23 active companies, there are currently 17 commercial and 6 clinical…
$SRPT Very sad news today of a second patient death on ELEVYDIS. Gene therapies hold tremendous promise, but safety must be paramount. It's becoming increasingly clear that low viral doses, less immunogenicity, and local delivery of therapies (when possible) are key factors for…
3 Followers 71 FollowingVINCIH AI SOLUTIONS..
we teach/help Businesses, enterpreneurs and investors automate and integrate AI into thier Businesses and Finance...
14 Followers 213 FollowingI ghostwrite email courses that convert wellness and fitness subscribers into paying clients through strategic educational sequences that build trust and sales.
217 Followers 285 FollowingMBChB, FANZCA / Investor / Father / Partner. Biotech plus some other stocks. Macro. Technical Analysis. Not investment advice.
313K Followers 4K FollowingThese posts were issued before my FDA employment and do not necessarily represent the views of the FDA or the United States. The account is now inactive.
2K Followers 406 FollowingAbeona Therapeutics (Nasdaq: ABEO) is a fully-integrated cell and gene therapy company at the forefront of the rapidly-advancing field of genetic medicine.
44K Followers 2K FollowingHelping Secure the Internet | Long Island elder emo surviving in ATX | Expect: infosec current events, DFIR, appsec & cloudsec - and me!
11K Followers 10 FollowingA @FuturumEquities Show brought to you by three LA boys with a passion for investing. Co-hosts @StockSavvyShay @LogicalThesis @samsolid57
340K Followers 59 FollowingReceive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or [email protected]. Privacy Policy - https://t.co/K2nAJlm94m.
2K Followers 2K FollowingPioneering Endovascular Robotics | Global leader in robotic technologies to enhance the treatment of arrhythmias & perform endovascular procedures
381 Followers 238 FollowingChairman & CEO of Stereotaxis. I spend my time at the intersection of technology, medicine and finance. I try to make the world a better place.
2K Followers 372 FollowingEmpowering Investors with Affordable Access to Experts. Research your stocks like the professionals do. Follow @SlingshotCtlyst for catalyst information!
167 Followers 5 FollowingEmpowering Investors with Affordable Access to Experts. Research your stocks like the professionals do. Follow @Slingshot_Invst for project information!
53K Followers 736 FollowingEarly stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
85K Followers 206 FollowingActivist short selling focused on frauds and promotes. Presume all tweets reflect short positions and biased opinion. Verify independently. Not inv advice.
2K Followers 499 FollowingI own only 1 stock at a time and try to dive deep as much as I could on that 1 stock. A risk taker, but also a very cautious one.
56K Followers 999 FollowingTechnical/Fundamental analyst, CPA, Owner of https://t.co/hO3l50hhRd, Investing in the Second Wave of AI, Join 17,000 other investors 👇
No recent Favorites. New Favorites will appear here.